GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Pre-Tax Income

Novartis AG (Novartis AG) Pre-Tax Income : $9,827 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Novartis AG's pretax income for the three months ended in Mar. 2024 was $3,129 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $9,827 Mil. Novartis AG's pretax margin was 25.82%.

During the past 13 years, Novartis AG's highest Pretax Margin was 55.78%. The lowest was 15.81%. And the median was 19.68%.


Novartis AG Pre-Tax Income Historical Data

The historical data trend for Novartis AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Pre-Tax Income Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,940.00 9,878.00 24,530.00 7,177.00 9,123.00

Novartis AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,520.00 2,769.00 1,552.00 2,377.00 3,129.00

Competitive Comparison of Novartis AG's Pre-Tax Income

For the Drug Manufacturers - General subindustry, Novartis AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Novartis AG's Pre-Tax Income falls into.



Novartis AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Novartis AG's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=9769+-227+-855+627+-191
=9,123

Novartis AG's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=3373+-29+-221+6+0
=3,129

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $9,827 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG  (OTCPK:NVSEF) Pre-Tax Income Explanation

Novartis AG's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=3129/12120
=25.82%

During the past 13 years, Novartis AG's highest Pretax Margin was 55.78%. The lowest was 15.81%. And the median was 19.68%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Novartis AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (Novartis AG) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.